Request Deal Involvement
Access Biotechnology led a $135m Series B round in Hemab.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Gorrissen Federspiel
legal advisors
Schulte Roth & Zabel
or
Principals
bidder
MAJ INVEST EQUITY A/S
bidder
THE INVUS GROUP LLC
target
HEMAB
bidder
ACCESS BIOTECHNOLOGY
bidder
DEEP TRACK CAPITAL
bidder
AVORO CAPITAL
bidder
ROCK SPRINGS CAPITAL
bidder
NOVO HOLDINGS A/S
bidder
RA CAPITAL MANAGEMENT
bidder
HEALTHCAP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite